Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies".

This measure would overturn a federal Medicare rule for 2025. That rule set payment rates for home health care and certain medical items, like disposable wound therapy devices and intravenous immune globulin (IVIG). It also added new reporting and participation rules for home health providers and long-term care facilities, including collecting more data on acute respiratory illnesses. By canceling the rule, those 2025 payment updates and reporting changes would not take effect. The original rule was issued on November 7, 2024 .

Key points:

• What it does: Cancels the 2025 Medicare home health payment update and related rules, including new reporting on acute respiratory illnesses .
• Who is affected: Home health agencies, long-term care facilities, and providers involved with disposable negative pressure wound therapy devices and IVIG under Medicare .
• Timing: Targets the rule issued November 7, 2024, for the 2025 calendar year .